Holen Sie sich die Stockscreener-App
5.60
0.18%
-0.01
Handel nachbörslich:
5.60
Schlusskurs vom Vortag:
$5.61
Offen:
$5.65
24-Stunden-Volumen:
97,968
Relative Volume:
0.44
Marktkapitalisierung:
$207.34M
Einnahmen:
$128.45M
Nettoeinkommen (Verlust:
$6.54M
KGV:
112.00
EPS:
0.05
Netto-Cashflow:
$-8.79M
1W Leistung:
-8.05%
1M Leistung:
-11.39%
6M Leistung:
-6.67%
1J Leistung:
-30.61%
1-Tages-Spanne:
$5.39
$5.65
1-Wochen-Bereich:
$5.39
$6.39
52-Wochen-Spanne:
$3.6793
$8.45
Lifecore Biomedical Inc Stock (LFCR) Company Profile
Firmenname
Lifecore Biomedical Inc
Sektor
Telefon
(952) 368-4300
Adresse
3515 LYMAN BOULEVARD, CHASKA
Vergleichen Sie LFCR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LFCR
Lifecore Biomedical Inc
|
5.60 | 207.34M | 128.45M | 6.54M | -8.79M | 0.05 |
|
ZTS
Zoetis Inc
|
165.31 | 74.02B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.15 | 45.90B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.08 | 44.64B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.23B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.57 | 13.67B | 612.78M | -86.37M | -62.91M | -0.87 |
Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-09-05 | Eingeleitet | Craig Hallum | Buy |
| 2024-08-28 | Herabstufung | Barrington Research | Outperform → Mkt Perform |
| 2023-03-20 | Herabstufung | Stephens | Overweight → Equal-Weight |
Lifecore Biomedical Inc Aktie (LFCR) Neueste Nachrichten
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
When the Price of (LFCR) Talks, People Listen - Stock Traders Daily
Lifecore Biomedical (NASDAQ:LFCR) Trading 3.8% HigherHere's What Happened - MarketBeat
NASDAQ: LFCR Lawsuit NOTICE: Investors Who Lost Money With Shares of Lifecore Biomedical, Inc. (NASDAQ: LFCR) Should Contact the Shareholders Foundation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - Markets Insider
Lifecore Biomedical (NASDAQ:LFCR) Stock Price Up 3.8% – Should You Buy? - Defense World
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - Markets Insider
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Markets Insider
(LFCR) Technical Data - Stock Traders Daily
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Shareholders to Inquire about Securities Investigation - Markets Insider
Sept. 27th Deadline Alert: Investors Who Lost More Than $100,000 With Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Should Contact the Shareholders Foundation - ACCESS Newswire
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Is Investigating Lifecore Biomedical, Inc. (LFCR) And Encourages Investors to Connect - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Stockholders to Inquire about Securities Investigation - Markets Insider
LFCR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Lifecore Biomedical, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Investors to Learn More About the Investigation - Markets Insider
Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - Markets Insider
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Stockholders to Learn More About the Investigation - Markets Insider
Lifecore Biomedical to Participate in 2025 BIO CEO & Investor Conference - The Manila Times
Bronstein, Gewirtz & Grossman, LLC Encourages Lifecore Biomedical, Inc. (LFCR) Investors to Inquire about Securities Investigation - Markets Insider
(LFCR) Investment Analysis - Stock Traders Daily
Lifecore Biomedical’s Earnings Call: Growth Amid Challenges - TipRanks
This Lifecore Biomedical Insider Increased Their Holding In The Last Year - Yahoo Finance
LFCR Investors Have Opportunity to Lead Lifecore Biomedical, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Shares Purchased by Barclays PLC - Defense World
Here are Laughing Water Capital’s Updates on Lifecore Biomedical (LFCR) - Insider Monkey
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Sees Significant Increase in Short Interest - Defense World
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Short Interest Update - MarketBeat
Lifecore Biomedical Announces Special Stockholder Meeting - The Manila Times
Lifecore Biomedical Calls Special Meeting to Vote on Preferred Stock Conversion Cap Removal - StockTitan
Jane Street Group LLC Increases Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
LFCR FY2025 EPS Forecast Boosted by Barrington Research - Defense World
LFCR FY2025 EPS Forecast Lifted by Barrington Research - MarketBeat
Paul Josephs Bought 3.1% More Shares In Lifecore Biomedical - Simply Wall St
Lifecore Biomedical, Inc. (NASDAQ:LFCR) CEO Paul Josephs Acquires 17,000 Shares - MarketBeat
Geode Capital Management LLC Increases Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Barclays PLC Has $147,000 Stock Position in Lifecore Biomedical, Inc. (NASDAQ:LFCR) - Defense World
Lifecore Biomedical to sell multi-purpose 10-head isolator filler - MSN
Lifecore Biomedical Sells Excess Capital Equipment for $17M - Contract Pharma
Lifecore Biomedical Further Strengthens Financial Position Through Sale of Excess Capital Equipment for $17 Million - The Manila Times
Lifecore Biomedical Secures $17M Equipment Sale, Doubles Production Capacity with New Filler - StockTitan
Lifecore Biomedical to Participate at 43rd Annual J.P. Morgan Healthcare Conference - The Manila Times
LFCR Stock Earnings: Lifecore Biomedical Beats EPS, Beats Revenue for Q2 2024 - MSN
Lifecore Biomedical to Present at 2025 J.P. Morgan Healthcare Conference in San Francisco - StockTitan
LFCR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces an Investigation into Lifecore Biomedical, Inc. and Encourages Investors to Contact the Firm - AccessWire
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q2 2025 Earnings Call Transcript - MSN
Lifecore Biomedical’s (LFCR) “Equal Weight” Rating Reaffirmed at Stephens - Defense World
Finanzdaten der Lifecore Biomedical Inc-Aktie (LFCR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.92%
1.31%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):